We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PATH:NYSEUiPath, Inc. analysis

Data as of Oct 17, 2026 - not real-time

Latest price
$12.85
Risk: high
9/10High risk

Summary

The moving-average structure behind UiPath, Inc. is neutral at $12.85, with no clear ordering between short and long averages. Over a rolling month the price has lost 29.5%. Relative strength is 42.6 — neutral — and the MACD signal is bullish. The recent range runs from support at $11.57 up to resistance at $14.00.
Valuation screens as undervalued: a P/E of 19.2 sits below the sector average of 30.0. Analyst price targets sit 20.6% above the current price. Revenue is growing at 13.4% on a 21.0% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 71.3%, a beta of 1.19 and a maximum drawdown of 51.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 86 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top market events

  • UiPath Inc. jumps as strong automation demand headlines fuel optimism, with stocks have been trading up by 4.29...
  • UiPath NYSE:PATH has been named a Leader in the 2026 Gartner Magic Quadrant for Intelligent Document Processing.
  • UiPath NYSE:PATH was named a Leader in The Forrester Wave for Adaptive Process Orchestration in a recent 2026 report.

Market outlook

Short term

< 1 year

Positive

Model confidence5/105 out of 10

Key factors

  • Trading above the 200-day average of 12.52
  • MACD momentum is positive
  • 30-day price change of -29.5%

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 19.2 versus sector average of 30.0
  • Trading above the 200-day average of 12.52
  • Analyst targets imply +20.6% versus the current price

Long term

> 3 years

Positive

Model confidence7/107 out of 10

Key factors

  • P/E of 19.2 versus sector average of 30.0
  • Analyst targets imply +20.6% versus the current price
  • Profit margin of 21.0% is healthy

Key metrics

Financial health

Revenue Growth13.40%
Profit Margin21.03%
P/E Ratio19.2
ROE20.03%
ROA3.66%
Debt/Equity4.09
P/B Ratio3.4
Op. Cash Flow$373.2M
Free Cash Flow$474.3M
Industry P/E30.0

Technical analysis

TrendNeutral
RSI42.6
Support$11.57
Resistance$14.00
MA 20$13.05
MA 50$14.69
MA 200$12.52
MACDBullish
VolumeDecreasing
Fear & Greed Index85.73

Valuation

Fair Value$21.51
Target Price$15.50
Upside/Downside20.61%
GradeUndervalued
TypeBlend

Risk assessment

Beta1.19
Volatility71.34%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.